BeiGene Ltd. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (9)

Latest Posts

About This Stock More About This Stock
Week In Review: Fosun Eyeing $4 Billion Bid For Germany's Stada Pharma
Article By: ChinaBio® Today
Saturday, March 11, 2017 1:52 PM EDT
Shanghai Fosun Pharma is said to be contemplating a bid for Germany's Stada Arzneimittel, a well established generic drug company.
In this article: BGNE, BYSI
Read
Week In Review: China's New Century Healthcare Plans Hong Kong IPO
Article By: ChinaBio® Today
Saturday, December 31, 2016 7:09 PM EDT
New Century Healthcare, which operates three pediatric clinics and recently acquired a women's hospital, all in Beijing, was approved to stage a $100 million IPO on the Hong Kong exchange. It's expected to take place in January 2017.
In this article: BGNE
Read
Week In Review: Beijing's Berry Genomics Valued At $619 Million In Reverse Merger
Article By: ChinaBio® Today
Saturday, December 24, 2016 4:36 PM EDT
Berry Genomics, a Beijing genetic testing company, will IPO via a reverse merger with Chengdu Tianxing Instrument & Meter (SHZ: 0710) at a valuation of $619 million on China's Shenzhen market.
In this article: SVA, BGNE
Read
Week In Review: JHL Biotech Signs $257 Million Biosimilar Deal With Sanofi
Article By: ChinaBio® Today
Saturday, December 10, 2016 12:44 PM EDT
JHL Biotech, a Taiwan-China biologics company, signed a $257 million partnership agreement that gives Sanofi rights to market a JHL clinical-stage rituximab biosimilar, initially for China.
In this article: AZN, NVS, SNY, CGIX, BGNE
Read
Week In Review: Beijing's BeiGene Raises $185 Million For Clinical Trial Program
Article By: ChinaBio® Today
Saturday, November 26, 2016 2:06 PM EDT
BeiGene, a Beijing novel oncology biopharma, completed a $200 million secondary offering last week, up from its initial target of $150 million.
In this article: BGNE
Read

PARTNER HEADLINES

Latest Tweets for $BGNE

No tweets yet!